Disruptions during wound healing phases (inflammation, proliferation, and remodeling) can result in scar formation. Higher levels of inflammatory markers (TGF-β1, TGF- β2, VEGF) and type 1 collagen are present in scars. Current treatments for scars incl (IMAGE)

ELSP

Disruptions during wound healing phases (inflammation, proliferation, and remodeling) can result in scar formation. Higher levels of inflammatory markers (TGF-β1, TGF- β2, VEGF) and type 1 collagen are present in scars. Current treatments for scars incl

Caption

Disruptions during wound healing phases (inflammation, proliferation, and remodeling) can result in scar formation. Higher levels of inflammatory markers (TGF-β1, TGF- β2, VEGF) and type 1 collagen are present in scars. Current treatments for scars include pressure garments, corticosteroids, laser therapy, and scar excision. Current research explores Yes-associated protein and harnesses TGF-β inhibition to reduce scaring.

Credit

Shi Fu, Niharika Singh, Shiffoni Sukhlal, Huiting Luo, Divleen K. Singh, Mimi R Borrelli, Duc Bui, Sami Khan, Alexander B. Dagum and Gurtej Singh*/ Stony Brook University, USA

Usage Restrictions

Credit must be given to the creator.

License

CC BY

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.